Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Malcom Rodman currently holds 4,584 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Malcom Rodman has been a net seller of MLYS stock. They have purchased $0 and sold $4.7M worth of shares.
David Malcom Rodman's most recent insider trade was on Apr 17, 2026, when they sold 416 shares at $0.00 per share.
David Malcom Rodman serves as Executive at Mineralys Therapeutics, Inc. (MLYS). They have executed 91 insider transactions totaling $4.7M over their tenure at the company.
David Malcom Rodman holds the position of Executive at Mineralys Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
David Malcom Rodman has shown a selling trading pattern, with $0 in total purchases and $4.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Malcom Rodman was on Oct 15, 2025, when they sold $446.0K worth of MLYS shares. This transaction involved 10,369 shares at $43.01 per share.
David Malcom Rodman currently owns 4,584 shares of Mineralys Therapeutics, Inc. (MLYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Malcom Rodman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Malcom Rodman has 91 Form 4 filings on record as an insider at Mineralys Therapeutics, Inc..
Set alerts for David Malcom Rodman and 40,000+ other insiders.